
BCSF
Bain Capital Specialty Finance Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
15.1468
Open
15.110
VWAP
--
Vol
213.74K
Mkt Cap
967.84M
Low
14.820
Amount
--
EV/EBITDA(TTM)
12.40
Total Shares
64.56M
EV
2.39B
EV/OCF(TTM)
81.59
P/S(TTM)
3.68
Bain Capital Specialty Finance, Inc. is an externally managed specialty finance company focused on lending to middle market companies. The Company's investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including first lien, first lien/last out, unitranche and second lien debt, investments in strategic joint ventures, equity investments and, to a lesser extent, corporate bonds. Its primary focus is capitalizing on opportunities within Bain Capital Credit's Senior Direct Lending Strategy, which seeks to provide risk-adjusted returns and current income to investors by investing primarily in middle-market direct lending opportunities across North America, Europe and Australia and also in other geographic markets. It may also invest in mezzanine debt and other junior securities, including common and preferred equity and in secondary purchases of assets or portfolios. It is managed by BCSF Advisors, LP.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q1
FY2024Q4
67.88M
-6.07%
0.440
-13.73%
71.00M
-4.7%
0.473
-10.69%
67.50M
-9.94%
0.473
-7.19%
Estimates Revision
The market is revising No Change the revenue expectations for Bain Capital Specialty Finance, Inc. (BCSF) for FY2024, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -2.48%.
Revenue Estimates for FY2024
No Change

0.00%
In Past 3 Month
EPS Estimates for FY2024
No Change

0.00%
In Past 3 Month
Stock Price
Go Down

-2.48%
In Past 3 Month
2 Analyst Rating

10.59% Upside
Wall Street analysts forecast BCSF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BCSF is 16.50 USD with a low forecast of 16.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy

10.59% Upside
Current: 14.920

Low
16.00
Averages
16.50
High
17.00

10.59% Upside
Current: 14.920

Low
16.00
Averages
16.50
High
17.00
Keefe, Bruyette & Woods
Paul Johnson
Hold
Maintains
$18 → $17
2025-04-08
Reason
Keefe, Bruyette & Woods
Paul Johnson
Price Target
$18 → $17
2025-04-08
Maintains
Hold
Reason
Keefe, Bruyette & Woods
Paul Johnson
Hold
Maintains
$17 → $18
2025-03-04
Reason
Keefe, Bruyette & Woods
Paul Johnson
Price Target
$17 → $18
2025-03-04
Maintains
Hold
Reason
Wells Fargo
Finian O'Shea
Buy
Maintains
$18 → $19
2025-03-03
Reason
Wells Fargo
Finian O'Shea
Price Target
$18 → $19
2025-03-03
Maintains
Buy
Reason
Wells Fargo
Finian O'Shea
Buy
Maintains
$17 → $18
2025-01-29
Reason
Wells Fargo
Finian O'Shea
Price Target
$17 → $18
2025-01-29
Maintains
Buy
Reason
Keefe, Bruyette & Woods
Paul Johnson
Hold
Maintains
$17
2024-08-21
Reason
Keefe, Bruyette & Woods
Paul Johnson
Price Target
$17
2024-08-21
Maintains
Hold
Reason
Wells Fargo
Finian O'Shea
Buy
Maintains
$18 → $17
2024-08-08
Reason
Wells Fargo
Finian O'Shea
Price Target
$18 → $17
2024-08-08
Maintains
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Bain Capital Specialty Finance Inc (BCSF.N) is 7.52, compared to its 5-year average forward P/E of 8.66. For a more detailed relative valuation and DCF analysis to assess Bain Capital Specialty Finance Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
8.66
Current PE
7.52
Overvalued PE
10.28
Undervalued PE
7.04
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
4.11
Current PS
3.39
Overvalued PS
4.94
Undervalued PS
3.28
Financials
Annual
Quarterly
FY2025Q1
YoY :
-16.35%
63.28M
Total Revenue
FY2025Q1
YoY :
-10.43%
48.53M
Operating Profit
FY2025Q1
YoY :
-18.66%
28.55M
Net Income after Tax
FY2025Q1
YoY :
-18.52%
0.44
EPS - Diluted
FY2025Q1
YoY :
-0.07%
98.87
Gross Profit Margin - %
FY2025Q1
YoY :
-2.74%
45.12
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
25.1K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 136.38% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
25.1K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
BCSF News & Events
Events Timeline
2025-05-05 (ET)
2025-05-05
17:07:13
Bain Capital Specialty Finance reports Q1 NII 50c, consensus 47c

2025-04-14 (ET)
2025-04-14
06:18:25
Bain Capital reaches agreement with Ageas to sell esure for GBP 1.295B

2025-03-30 (ET)
2025-03-30
19:14:10
Bain's Virgin Australia to meet with investors to relist on ASX, Reuters says


Sign Up For More Events
Sign Up For More Events
News
8.0
06-06NASDAQ.COMWhy Buy "Broke" Blue Chips? These 5 Small Caps Pay up to 17%
8.5
05-09Investing.comBain Capital in discussion to acquire PCI Pharma for $10 billion - Bloomberg By Investing.com
8.5
05-09SeekingAlphaBain Capital to sell China data centre business likely over $4B - report
Sign Up For More News
People Also Watch

AMAL
Amalgamated Financial Corp
29.290
USD
-1.15%

ACMR
ACM Research Inc
32.060
USD
+1.20%

SNDX
Syndax Pharmaceuticals Inc
9.990
USD
-3.48%

VTEX
VTEX
6.010
USD
-2.75%

PEBO
Peoples Bancorp Inc
29.150
USD
-0.65%

CTOS
Custom Truck One Source Inc
5.700
USD
-1.38%

PUMP
ProPetro Holding Corp
5.610
USD
-11.51%

LX
Lexinfintech Holdings Ltd
6.140
USD
-4.06%

DAVE
Dave Inc
240.200
USD
+9.07%
FAQ

What is Bain Capital Specialty Finance Inc (BCSF) stock price today?
The current price of BCSF is 14.92 USD — it has decreased -1.19 % in the last trading day.

What is Bain Capital Specialty Finance Inc (BCSF)'s business?

What is the price predicton of BCSF Stock?

What is Bain Capital Specialty Finance Inc (BCSF)'s revenue for the last quarter?

What is Bain Capital Specialty Finance Inc (BCSF)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Bain Capital Specialty Finance Inc (BCSF)'s fundamentals?

How many employees does Bain Capital Specialty Finance Inc (BCSF). have?
